Infographic. Needle and syringe distribution and opioid agonist treatment coverage in relation to WHO 2020 targets

This resource is part of the European Drug Report 2023, the EMCDDA's annual overview of the drug situation in Europe.

The coverage is based on the latest national estimates of injecting drug use and high-risk opioid use matched by harm reduction activity data (within a maximum of 2 years). The estimate of coverage of opioid agonist treatment for Belgium is derived from a subnational study conducted in 2019.

Source data

The data used to generate infographics and charts on this page may be found below.

List of tables

Table 1. Number of European countries implementing harm reduction interventions, up to 2022
Year Drug checking Drug consumption rooms Methadone maintenance treatment Needle and syringe programmes Take-home naloxone
1967     1    
1968     2    
1969          
1970     3    
1971          
1972          
1973          
1974     4    
1975     5    
1976          
1977     6    
1978          
1979          
1980          
1981          
1982          
1983          
1984       2  
1985       3  
1986       6  
1987     8 7  
1988       8  
1989     9 11  
1990     11 13  
1991     12    
1992 1   15 14  
1993     16 16  
1994     17 19  
1995     20 21  
1996 2   22    
1997 5   23 25  
1998     26 26  
1999          
2000       27  
2001 7   27    
2002          
2003          
2004          
2005          
2006          
2007       28  
2008          
2009          
2010         1
2011          
2012          
2013         2
2014 8       4
2015   1     6
2016 9 2     7
2017   6     9
2018 10 8     11
2019   9     13
2020 12       15
2021          
2022 12 10 27 28 16

Back to list of tables  

Table 2. Availability of take-home naloxone in Europe
Country Availability
Austria Available
Belgium Not available
Bulgaria Not available
Croatia Not available
Cyprus Available
Czechia Available
Denmark Available
Estonia Available
Finland Not available
France Available
Germany Available
Greece Not available
Hungary Not available
Ireland Available
Italy Available
Latvia Not available
Lithuania Available
Luxembourg Not available
Malta Not available
Netherlands Not available
Norway Available
Poland Not available
Portugal Available
Romania Not available
Slovakia Not available
Slovenia Available
Spain Available
Sweden Available
Türkiye Not available

Back to list of tables  

Table 3. Needle and syringe distribution and opioid agonist treatment coverage in relation to WHO 2020 targets, 2021 or latest available estimate
Country Proportion in opioid agonist treatment Syringes per person who injects drugs Number people who inject drugs
Croatia 0.5 43 6344
Cyprus 0.17 8 627
Czechia 0.59 232 40500
Finland 0.18 264 25000
France 0.78 118 106857
Greece 0.85 234 2462
Italy 0.27 5 105652
Latvia 0.1 145 7715
Lithuania 0.15 30 8868
Luxembourg 0.86 523 822
Norway 0.86 482 7878
Portugal 0.64 86 13162
Spain 0.9 181 8582
Belgium 0.72 172 7018

Back to list of tables  

Table 4. Location and number of drug consumption facilities throughout Europe
City Country lat lon Number of facilities
Brussels Belgium 50.84 4.35 1
Liege Belgium 50.6278 5.57459 1
Aarhus Denmark 56.14597 10.19845 1
Copenhagen Denmark 55.67453 12.5677 2
Odense Denmark 55.39509 10.38202 1
Vejle Denmark 55.70232 9.522832 1
Paris France 48.8539 2.34879 1
Strasbourg France 48.579 7.73633 1
Berlin Germany 52.504671 13.3945135 3
Bielefeld Germany 52.02656 8.540516 1
Bochum Germany 51.4815 7.2244 1
Bonn Germany 50.78 7.1778 1
Dortmund Germany 51.56247 7.45377 1
Düsseldorf Germany 51.2397 6.6778 1
Essen Germany 51.4798 7.0569 1
Frankfurt Germany 50.20948 8.76 4
Hamburg Germany 53.56828 9.999227 5
Hannover Germany 52.37608 9.73263 1
Karlsruhe Germany 49.012 8.390306 1
Köln Germany 50.93167 6.949464 1
Münster Germany 51.95222 7.623233 1
Saarbrücken Germany 49.24041 6.98665 1
Troisdorf Germany 50.818 7.14125 1
Wuppertal Germany 51.24225 7.158186 1
Athens Greece 38 23.7 1
Esch-sur-Alzette Luxembourg 49.50245 5.97222 1
Luxembourg Luxembourg 49.6503 6.2512 1
Almere Netherlands 52.3829 5.2887 1
Amsterdam Netherlands 52.414 4.90793 3
Apeldoorn Netherlands 52.1813 6.00827 1
Arnhem Netherlands 51.98497 5.899034 1
Deventer Netherlands 52.29638 6.178408 1
Enschede Netherlands 52.1988 6.87604 1
Haarlem Netherlands 52.389 4.6896 1
Heerlen Netherlands 50.8888 5.9811 1
Leeuwarden Netherlands 53.1987 5.8322 1
Leiden Netherlands 52.1597 4.4811544 1
Maastricht Netherlands 50.8541 5.69063 1
Nijmegen Netherlands 51.81272 5.842056 2
Roermond Netherlands 51.2248 5.9753 1
Rotterdam Netherlands 51.8882 4.6136 4
s-Hertogenbosch Netherlands 51.69714 5.305474 1
Tilburg Netherlands 51.60593 5.14963 1
Utrecht Netherlands 52.086 5.1127 1
Vlissingen Netherlands 51.42818 3.52915 1
Zwolle Netherlands 52.54429 6.09052 1
Bergen Norway 60.3954 5.33062 1
Oslo Norway 59.920979 10.753526 1
Porto Portugal 41.149 -8.610 1
Lisbon Portugal 38.716311 -9.142432 2
Badalona Spain 41.450142 2.24742 1
Barcelona Spain 41.3825 2.1769 9
Bilbao Spain 43.2569 -2.9236 1
Lleida Spain 41.61898 0.6201 1
Reus Spain 41.14994 1.10571 2
Sant Adrià de Besòs Spain 41.430599 2.21824 1
Tarragona Spain 41.1186 1.24047 1

Back to list of tables  

Originally published in

European Drug Report 2023: Trends and Developments

Related

Main subject
Keywords
Target audience
Type
  • Creative Commons Attribution 4.0 International (CC BY 4.0)

Related assets in the Media library

Screenshot of the Euro-DEN data explorer tool
Data explorer. Acute drug-toxicity presentations to emergency services by year, hospital and reported drug (Euro-DEN plus)
Bubble chart shows how countries have met needle and syringe distribution and opioid agonist treatment coverage goals in relation to WHO 2020 targets. Only a small number of countries have met both goals (Luxembourg, Norway, Czechia and Greece)
Infographic. Needle and syringe distribution and opioid agonist treatment coverage in relation to WHO 2020 targets
chart shows cumulative number of countries implementing different types of opioid agonist treatment by year.
Infographic. Number of European countries implementing opioid agonist treatment, up to 2022
Screenshot of clients in opioid agonist treatment in Europe infographic
Infographic. Clients in opioid agonist treatment
plot shows how countries are meeting WHO target for opioid agonist treatment coverage. The majority of countries in Europe meet the target, with the exception of seven countries, mainly in the East of Europe.
Infographic. Coverage of opioid agonist treatment in 2021 or the most recent year and in the previous estimate
Thumbnail of the recording of the EMCDDA webinar on young people and drug use
EMCDDA Webinar: Young people and drug use — how can we keep them safe?
Top